Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Carisma Therapeutics Inc CARM

Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on utilizing its proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. It is developing a pipeline of product candidates, with an initial focus on advancing multiple ex vivo autologous and in vivo CAR-M therapies for the... see more

Recent & Breaking News (NDAQ:CARM)

Sesen Shareholder Notice

Newsfile September 5, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sesen Bio, Inc. of Class Action Lawsuit and Upcoming Deadline - SESN

PR Newswire September 5, 2021

Lost Money in Sesen Bio, Inc.?

Business Wire September 3, 2021

SESN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 18, 2021 in the Class Action Filed on Behalf of Sesen Bio, Inc. Limited Shareholders

Newsfile September 3, 2021

Sesen Shareholder Notice

Newsfile September 3, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sesen Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 18, 2021 - SESN

Newsfile September 3, 2021

INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Sesen Bio, Inc. (SESN) Investors and Encourages Investors to Contact the Firm Before October 18, 2021

Business Wire September 3, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of COIN, PLL and SESN

Accesswire September 3, 2021

Lawsuits Filed Against YMM, COIN and SESN - Jakubowitz Law Pursues Shareholders Claims

Accesswire September 3, 2021

CLASS ACTION UPDATE for JRVR, PLL and SESN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire September 3, 2021

SESN Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Sesen Bio, Inc. Investors With Losses Exceeding $400K of Class Action and Encourages Investors to Contact the Firm

Newsfile September 3, 2021

SHAREHOLDER ALERT: ITRM SESN SPPI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Accesswire September 3, 2021

Pomerantz Law Firm Announces the Filing of a Class Action Against Sesen Bio, Inc. and Certain Officers - SESN

Newsfile September 2, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CRMD, ATVI and SESN

Accesswire September 2, 2021

Sesen Shareholder Alert

Newsfile September 2, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of AHCO, ATIP and SESN

Accesswire September 2, 2021

SHAREHOLDER ALERT: PLL LIVE SESN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Accesswire September 2, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sesen Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 18, 2021 - SESN

Newsfile September 1, 2021

Sesen Deadline Alert

Newsfile September 1, 2021

LAWSUITS FILED AGAINST LOTZ, CRMD and SESN - Jakubowitz Law Pursues Shareholders Claims

Accesswire September 1, 2021